Check your eligibility now & get in touch with a study center

CHECK ELIGIBILITY

What Works and Why? Eye Movement Desensitization and Reprocessing as a Potential Treatment for Substance Use Disorders

Substance Use Disorders (SUD) are often comorbid with psychological trauma, however, the complex interaction between the two is not yet fully understood. Most addiction-specialized professionals do not engage in exploring past traumatic experiences of the patients due to personal, professional, and educational barriers. Therefore, psychological trauma remains highly undetected and its contribution to the development and maintenance of SUD is neglected. This compromises the therapeutic results of most interventions, with relapse rates in SUD still remaining impressively high. EMDR is one of the most effective interventions for Post-Traumatic Stress Disorder (PTSD), and has been applied to other disorders that are often comorbid with trauma, such as psychosis and depression, with promising results. Nevertheless, its application in SUD is still limited. Taken altogether, there is a need to clarify the efficacy of Eye Movement Desensitization and Reprocessing (EMDR) therapy in SUD, as well as the mechanisms of action that mediate its potential therapeutic effects.

The aim of this study is to 1) determine the efficacy of EMDR therapy in patients with SUD comorbid with psychological trauma, as well as whether changes in these clinical variables correspond to changes in salivary cortisol levels- a robust marker of the Hypothalamic-Pituitary-Adrenal (HPA) axis; 2) investigate the mechanisms of action of EMDR therapy, paying special attention to the key role that the cerebellum might play in mediating its therapeutic effects.

Highlighted Text Block

You can use content blocks to arrange your articles, large texts, instructions. Combine these blocks with media blocks to add illustrations and video tutorials. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links.

Diabetes

What is Diabetes?

A large percentage of viewers are on mobile devices, so keep it short and to the point. Have you ever noticed how long a 5 sentence paragraph looks on a smart phone? If you read it via desktop/laptop, you realize it is really not that much information. A suggestion is to plan on “marrying” the two and keep the chatter down. Conversely, don’t sacrifice the “meat and potatoes” of what you’re trying to convey; this will help to keep the organic SEO strong.

What causes Diabetes?

Viewers need to be given a direction every now and then. Use your headers to draw the eye where you want it. Imagine the website as a term paper and your outline will guide your structure. Focus broad topics on the main headers and help guide the viewer down the right path! Appropriately introducing call-to-action buttons also helps with guiding the reader and connecting content writing with your website’s goal.

How is Diabetes treated?

Here are a few website content writing tips to make sure your website content gets the attention it deserves • Know your audience • Write short, simple sentences – Nix the jargon – Mix up your word choice • Make text scannable • Incorporate multimedia Capturing reader’s interests with good website content and information can be challenging. Most visitors will spend just a few seconds on a webpage, before deciding what to do next. Therefore, good website writing is the key to beating these odds.

More information about Diabetes

National Diabetes Foundation National Diabetes Foundation – Support Network American Academy of Diabetes International Diabetes Council International Federation of Diabetes Associations

Call 1800-9860-568 now to find out if you are eligible.

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.

content image
Diabetes

A short sentence to introduce what to expect in the about condition section

Learn more
The Study

A short sentence to introduce what to expect in the about condition section

Learn more
About Clinical Trials

A short sentence to introduce what to expect in the about condition section

Learn more

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.

content image
content image

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.

content image